Literature DB >> 12736716

The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.

Gerold Hoever1, Bettina Groeschel, Prakash Chandra, Hans W Doerr, Jindrich Cinatl.   

Abstract

The human T-lymphoid cell line H9 resistant to 3'-azido-2',3'-dideoxythymidine (AZT) has a very low level of thymidine kinase (TK) expression which accounts for the failure of AZT to inhibit HIV-1 replication. In the present study DNA methylation and histone deacetylation as possible mechanisms of decreased TK gene expression in the resistant cells were investigated. The resistant cells expressed high levels of DNA methyltransferases (DNMTs) 3a and 3b. The DNA methylation inhibitor, 5-aza-cytidine (5-aza-C), increased TK gene expression and antiviral activity of AZT in the resistant cells, while histone deacetylase inhibitor trichostatin A (TSA) had no effect. The results suggest that hypermethylation of the TK gene but not histone deacetylation in AZT-resistant H9 cells accounts for decreased TK gene expression and failure of AZT to inhibit HIV-1 replication probably due to overexpression of DNMT 3a and 3b.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736716

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.

Authors:  Serguei V Vinogradov; Ekta Kohli; Arin D Zeman
Journal:  Pharm Res       Date:  2006-05-02       Impact factor: 4.200

2.  Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells.

Authors:  Ofelia A Olivero; Irma L Vazquez; Catherine C Cooch; Jessica Ming; Emily Keller; Mia Yu; Jennifer P Borojerdi; Hannan M Braun; Edward McKee; Miriam C Poirier
Journal:  Toxicol Sci       Date:  2010-01-27       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.